Results 41 to 50 of about 4,859,269 (256)
Zdorovʹe Rebenka, 2019 We consider it is reasonable to use symptomatic therapy in all cases of uncomplicated acute respiratory viral infections, which are self-eliminating diseases.
E.A. Agafonova +3 more
doaj +1 more source
Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy
FEBS Letters, EarlyView.The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley +1 more source
Journal of Education, Health and Sport, 2019 There was conducted an epidemiological study of the morbidity of non-tumour diseases of the respiratory organs of the first-generation offspring born by residents of radioactively contaminated territories, until they reached 18 years.
Zh. Yaroshenko
doaj +1 more source
Unlocking the potential of cell‐permeable nanobodies for intracellular applications
FEBS Letters, EarlyView.This review outlines current strategies for delivery of nanobodies into cells and highlights recent examples of functional applications. By addressing and manipulating intracellular targets, these molecules hold great potential for treating cancer, respiratory diseases and neurological disorders, making this a vibrant area of research in the biomedical
Mariona Gené‐Verdés +2 more
wiley +1 more source
Patologìâ, 2019 Aim. Determine the activity of apoptosis processes in young children with anemia of inflammation acquired on the background of acute bacterial diseases of respiratory organs. Material and methods.
H. O. Lezhenko +2 more
doaj +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
TO A QUESTION ON SYMPTOMATIC TREATMENT OF ACUTE RESPIRATORY INFECTIONS
Педиатрическая фармакология, 2008 The authors consider the symptomatic therapy of acute respiratory diseases among children. They also discuss the application efficiency and safety of the local vasoconstrictors (decongestants).Key words: acute respiratory diseases, symptomatic therapy ...
V.К. Tatochenko
doaj +2 more sources
TOPICAL IMMUNOMODULATOR IN PROPHYLAXIS AND TREATMENT OF ACUTE RESPIRATORY INFECTIONS IN CHILDREN
Вопросы современной педиатрии, 2012 The bacterial lysates mechanism of action on the children immune system increasing the organism resistance against upper respiratory tract infections is described in this article.
V. V. Chernikov
doaj +1 more source
Journal of Inflammation, 2023 Background Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS) are life threatening pulmonary diseases, and we are now lack of effective therapeutic methods. Inflammatory responses are essential for initiating ALI/
Chunguang Yan +5 more
doaj +1 more source
Molecular Oncology, EarlyView.LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source